$3.50 +0.06 (%) Corcept Therapeutics Inc - NASDAQ

Feb. 9, 2016 | 04:00 PM

Partner Headlines

  1. Corcept Therapeutics Announces Preliminary Fourth Quarter and Full Year 2015 Summary Financial ...

    GuruFocus | Jan. 28, 2016 | 23:04PM EST
  2. Corcept Therapeutics to Announce Preliminary 2015 Financial Results, Provide 2016 Revenue ...

    GuruFocus | Jan. 21, 2016 | 23:05PM EST
  3. Mid-Morning Market Update: Markets Edge Lower; Cal-Maine Misses Q2 Expectations

    Benzinga | Dec. 24, 2015 | 10:08AM EST
  4. Corcept Therapeutics Announces Initial Efficacy Results in Phase 1/2 Trial of Mifepristone in ...

    GuruFocus | Dec. 14, 2015 | 23:04PM EST
  5. David Swensen's Transactions Show Diversity of Portfolio

    GuruFocus | Nov. 19, 2015 | 10:28AM EST
  6. Corcept Therapeutics to Announce Third Quarter Financial Results and Corporate Update and Host ...

    GuruFocus | Oct. 30, 2015 | 00:02AM EST
  7. Results of Phase 1 Trial of Next-Generation Cortisol Modulator CORT125134 to Be Presented at ...

    GuruFocus | Oct. 14, 2015 | 00:03AM EST
  8. Corcept Therapeutics Appoints Robert S. Fishman, M.D., as Chief Medical Officer

    GuruFocus | Sep. 29, 2015 | 00:01AM EST
  9. Corcept Therapeutics to Announce Second Quarter Financial Results and Corporate Update and Host ...

    GuruFocus | Jul. 30, 2015 | 00:03AM EST
  10. Mid-Day Market Update: Dow Dips Over 1%; Harley-Davidson Shares Rise On Earnings Beat

    Benzinga | Jul. 21, 2015 | 12:46PM EST
  11. Benzinga's Top Initiations

    Benzinga | Apr. 21, 2015 | 09:36AM EST
  12. Two Stocks for the Value Investor and GAARP Enthusiast

    GuruFocus | Jun. 7, 2014 | 12:54PM EST
  13. Morning Market Losers

    Benzinga | May. 7, 2014 | 09:48AM EST
  14. UPDATE: Stifel Terminates Coverage on Corcept Therapeutics Due to Reallocation of Resources

    Benzinga | Mar. 10, 2014 | 09:40AM EST
  15. UPDATE: Stifel Downgrades Corcept Therapeutics, See Gradual Progress with Korlym

    Benzinga | Jan. 13, 2014 | 08:13AM EST
  16. Corcept Therapeutics Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 8, 2012 | 12:06PM EST
  17. UPDATE: Oppenheimer Downgrades Corcept Therapeutics to Perform on Disappointing Sales

    Benzinga | Nov. 2, 2012 | 08:45AM EST
  18. UPDATE: Piper Jaffray Downgrades Corcept Therapeutics to Neutral on Korlym Outlook

    Benzinga | Sep. 13, 2012 | 05:33AM EST
  19. Corcept Therapeutics Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 9, 2012 | 13:33PM EST
  20. Equity Moves on Sell-Side Sentiment for July 13, 2012

    Benzinga | Jul. 13, 2012 | 09:11AM EST
  21. UPDATE: Bank of America Initiates Corcept Therapeutics at Underperform on Korlym Launch Caution

    Benzinga | Jul. 13, 2012 | 02:37AM EST
  22. Parametric Technology, Generac Holdings Among Stocks Down on High Volume Monday

    FoxBusiness | Jul. 2, 2012 | 06:32AM EST
  23. UPDATE: Stifel Nicolaus Increases Target to $9 on Concept Therepeutics

    Benzinga | Feb. 21, 2012 | 02:37AM EST
  24. Corcept Therapeutics Pops 61% After Friday's FDA Approval

    Benzinga | Feb. 21, 2012 | 02:13AM EST
  25. Notable Call Options Activity in Corcept Therapeutics

    Benzinga | Jan. 31, 2012 | 07:09AM EST
  26. Notable Put Options Activity in Corcept Therapeutics

    Benzinga | Jan. 5, 2012 | 05:42AM EST
Trading Center